. Conseil, Agence de la biomédecine http://www.agence-biomedecine.fr/uploads/document/rapport-bilan-LB-oct2008.pdf Biotechnology and Biological Sciences Research Council and Medical Research Council in collaboration with the Sciencewise Expert Resource Centre Stem cell dialogue, Leçons d'expérience 2005-2008 », 2008.

N. Brown, Shifting Tenses: Reconnecting Regimes of Truth and Hope, Configurations, vol.13, issue.3, pp.331-355, 2007.
DOI : 10.1353/con.2007.0019

L. Coulombel, Pluripotence : une d??finition ?? g??om??trie variable, Médecine Sciences, pp.798-801, 2009.
DOI : 10.1051/medsci/20092510798

D. Dickenson, Property in the body: Feminist perspectives, 2007.

E. Elstner, A. Damaschun, A. Kurtz, G. Stacey, B. Aran et al., The changing landscape of European and international regulation on embryonic stem cell research, Stem Cell Research, vol.2, issue.2, pp.101-107, 2009.
DOI : 10.1016/j.scr.2008.10.003

A. Faulkner, Regulatory policy as innovation: Constructing rules of engagement for a technological zone of tissue engineering in the European Union, Research Policy, vol.38, issue.4, pp.637-683, 2008.
DOI : 10.1016/j.respol.2009.01.017

H. Gottweiss, Biobanks: Governance in Comparative Perspective, 2008.

H. Gottweiss, B. Salter, and . Catherine, The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition, 2009.
DOI : 10.1057/9780230594364

K. J. Hewitt, Y. Shamis, R. B. Hayman, M. Margvelashvili, S. Dong et al., Epigenetic and Phenotypic Profile of Fibroblasts Derived from Induced Pluripotent Stem Cells, PLoS ONE, vol.3, issue.2, pp.1-11, 2011.
DOI : 10.1371/journal.pone.0017128.s002

A. Mahalatchimy, E. Rial-sebbag, V. Tournay, A. Faulkner, and . Debate, Ética y medicina regenerativa 34 DILEMATA, pp.17-37, 2011.

L. Douarin and N. , Des chimères, des clones et des gènes, 2000.

A. Mahalatchimy, Access to Advanced Therapy Medicinal Products in the EU: Where Do We Stand?, European Journal of Health Law, vol.18, issue.3, pp.305-317, 2011.
DOI : 10.1163/157180911X574146

P. Martin, N. Brown, and A. Turner, Capitalizing hope: the commercial development of umbilical cord blood stem cell banking, New Genetics and Society, vol.6, issue.2, pp.2-127, 2008.
DOI : 10.1038/nrg912

J. Mchale, The legal regulation of human material Principles of medical law, pp.1011-1050, 2010.

V. Michel, ) : « La compétence de la Communauté en matière de santé publique, pp.157-194, 2003.

S. Minger, Regenerative medicine, Regenerative Medicine, vol.1, issue.1, pp.1-2, 2006.
DOI : 10.2217/17460751.1.1.1

S. Sekiya and A. Suzuki, Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors, Nature, vol.32, issue.7356, pp.390-393, 2011.
DOI : 10.1038/ng1032

N. Stephens, P. Atkinson, and P. Et-glasner, The UK Stem Cell Bank as performative architecture, New Genetics and Society, vol.27, issue.2, pp.2-87, 2008.
DOI : 10.1215/9780822388043

N. Stephens, P. Atkinson, and P. Glasner, The UK Stem Cell Bank: Securing the Past, Validating the Present, Protecting the Future1, The UK Stem Cell Bank: Securing the Past, Validating the Present, Protecting the Future, pp.43-56, 2008.
DOI : 10.4324/9780203449721

N. Stephens, the UK stem cell bank : an institutional ecology, 2010.

K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka et al., Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors, Cell, vol.131, issue.5, pp.861-872, 2007.
DOI : 10.1016/j.cell.2007.11.019

V. Tournay, M. Ott, D. Bemme, and C. Routelous, The United Kingdom Stem Cell Bank, Sociologie et soci??t??s, vol.42, issue.2, pp.2-291, 2010.
DOI : 10.7202/045365ar

V. Tournay, Une prospective des pratiques associées aux cellules souches embryonnaires humaines en France. Besoins, enjeux et agencements des pratiques. La nécessité d'une banque physique: le modèle britannique, 2008.